Literature DB >> 2200277

Distribution and kinetics of glucose in rats analyzed by noncompartmental and compartmental analysis.

M Raman1, J Radziuk, G Hetenyi.   

Abstract

The steady-state kinetics and distribution of glucose were assessed using noncompartmental and various two-compartment models in rats that were infused with insulin (+/- euglycemic clamping), methylprednisolone (MP), or phlorizin (PHL) as well as rats injected with protamine-zinc-insulin (PZI) or rendered diabetic. Decreases in clearance of glucose (PCR) were greatest with insulin infusion, followed by PHL, MP, and PZI treatments. PCR decreased in diabetes to 25% of normal. With hyperinsulinemia and euglycemia, turnover rates were 1.18 times the rate of glucose infusion. In normal rats the ratio of the contents of the two compartments was 0.6-0.8 (depending on the model). Significant increases, of between 2.8 and 5.2, were observed with insulin infusion and between 0.8 and 1.8 with PHL, again depending on the model. Because PHL-induced changes in PCR are renal, these data suggest that variations in glucose distribution depend on changes in PCR as well as insulin. The intercompartmental rate constant decreased, and the noncompartmental volume of distribution increased to reflect the above changes. In non-steady-state studies, glucose release increased in response to insulin but not to PHL in contrast to other species.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200277     DOI: 10.1152/ajpendo.1990.259.2.E292

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Pharmacokinetic/pharmacodynamic modeling of GLP-1 in healthy rats.

Authors:  Yanguang Cao; Wei Gao; William J Jusko
Journal:  Pharm Res       Date:  2011-12-17       Impact factor: 4.200

2.  Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components.

Authors:  M Ader; T C Ni; R N Bergman
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

3.  Population pharmacodynamic modeling of exenatide after 2-week treatment in STZ/NA diabetic rats.

Authors:  Ting Chen; Leonid Kagan; Donald E Mager
Journal:  J Pharm Sci       Date:  2013-07-29       Impact factor: 3.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.